688161 威高骨科
已收盘 06-26 15:00:01
资讯
新帖
简况
威高骨科:每10股派发现金红利2.40元(含税)
证券之星 · 06-25
威高骨科:每10股派发现金红利2.40元(含税)
每周股票复盘:威高骨科(688161)拟每股派现0.24元
证券之星 · 06-20
每周股票复盘:威高骨科(688161)拟每股派现0.24元
威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%
证券之星 · 06-18
威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%
每周股票复盘:威高骨科(688161)2025年年度股东会顺利召开
证券之星 · 05-31
每周股票复盘:威高骨科(688161)2025年年度股东会顺利召开
威高骨科(688161)披露2025年年度股东会决议公告,5月28日股价下跌2.44%
证券之星 · 05-28
威高骨科(688161)披露2025年年度股东会决议公告,5月28日股价下跌2.44%
威高骨科新注册《制造生产数据采集与分析管理系统V1.0》等2个项目的软件著作权
证券之星 · 05-27
威高骨科新注册《制造生产数据采集与分析管理系统V1.0》等2个项目的软件著作权
每周股票复盘:威高骨科(688161)2025年净利增20.06%
证券之星 · 05-24
每周股票复盘:威高骨科(688161)2025年净利增20.06%
威高骨科(688161)披露2025年年度股东会会议资料,5月20日股价下跌1.66%
证券之星 · 05-20
威高骨科(688161)披露2025年年度股东会会议资料,5月20日股价下跌1.66%
每周股票复盘:威高骨科(688161)将参加2026年投资者网上集体接待日活动
证券之星 · 05-17
每周股票复盘:威高骨科(688161)将参加2026年投资者网上集体接待日活动
威高骨科(688161)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价下跌0.18%
证券之星 · 05-13
威高骨科(688161)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价下跌0.18%
每周股票复盘:威高骨科(688161)签订募集资金监管协议
证券之星 · 05-10
每周股票复盘:威高骨科(688161)签订募集资金监管协议
每周股票复盘:威高骨科(688161)Q1净利降14.6%
证券之星 · 05-02
每周股票复盘:威高骨科(688161)Q1净利降14.6%
威高骨科(688161)披露2026年第一季度报告,4月30日股价下跌5.24%
证券之星 · 04-30
威高骨科(688161)披露2026年第一季度报告,4月30日股价下跌5.24%
图解威高骨科一季报:第一季度单季净利润同比下降14.60%
证券之星 · 04-29
图解威高骨科一季报:第一季度单季净利润同比下降14.60%
威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%
证券之星 · 04-29
威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%
东吴证券:给予威高骨科买入评级
证券之星 · 04-06
东吴证券:给予威高骨科买入评级
股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%
证券之星 · 03-30
股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%
威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大
证券之星 · 03-29
威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大
威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%
证券之星 · 03-28
威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%
图解威高骨科年报:第四季度单季净利润同比增长2.99%
证券之星 · 03-28
图解威高骨科年报:第四季度单季净利润同比增长2.99%
加载更多
公司概况
公司名称:
山东威高骨科材料股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-06-30
主营业务:
山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨科植入物及耗材类产品、骨科智能设备与耗材类产品、功能修复与组织再生类产品。公司是国内产品线最全、规模领先的头部企业之一,市场份额增长远超行业平均增速。公司在国内市场上建立了较高的品牌知名度,在国产高端医疗器械领域具有较高的市场占有率。
发行价格:
36.22
{"stockData":{"symbol":"688161","market":"SH","secType":"STK","nameCN":"威高骨科","latestPrice":20.17,"timestamp":1782457201000,"preClose":20.94,"halted":0,"volume":933183,"delay":0,"changeRate":-0.0368,"floatShares":400000000,"shares":400000000,"eps":0.6528,"marketStatus":"已收盘","change":-0.77,"latestTime":"06-26 15:00:01","open":20.94,"high":21.16,"low":20.16,"amount":19119400,"amplitude":0.0478,"askPrice":20.17,"askSize":7,"bidPrice":20.15,"bidSize":15,"shortable":0,"etf":0,"ttmEps":0.6528,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.94,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782437400000,1782444600000],[1782450000000,1782457200000]],"highLimit":23.03,"lowLimit":18.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400000000,"isCdr":false,"pbRate":1.92,"roa":"--","peRate":30.897672,"roe":"1.06%","epsLYR":0.68,"committee":-0.34902,"marketValue":8068000000,"turnoverRate":0.0023,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-06-29。","afterMarket":{"amount":0,"volume":0,"close":20.17,"buyVolume":0,"sellVolume":0,"time":1782459237746,"indexStatus":"已收盘 06-26 15:30:00","preClose":20.94},"floatMarketCap":8068000000},"requestUrl":"/m/hq/s/688161","defaultTab":"news","newsList":[{"id":"2646382064","title":"威高骨科:每10股派发现金红利2.40元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646382064","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646382064?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:37","pubTimestamp":1782373056,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科06月25日在投资者关系平台上答复投资者关心的问题。另外,公司加大分红力度,截至目前,公司完成现金分红金额总计5.75亿元,占归母净利润的比例超过33%。公司将在6月26号实施2025年年度权益分派,每10股派发现金红利2.40元(含税),派发现金分红总额共计95,348,669.76元(含税),约占2025年度归母净利润的35.49%。股票价格受宏观环境、市场资金投资偏好分化等多重外部因素影响,敬请投资者注意短期投资风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500022931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644065057","title":"每周股票复盘:威高骨科(688161)拟每股派现0.24元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644065057","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644065057?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:22","pubTimestamp":1781896933,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,威高骨科报收于21.84元,较上周的22.32元下跌2.15%。本周,威高骨科6月15日盘中最高价报22.66元。威高骨科当前最新总市值87.36亿元,在医疗器械板块市值排名31/129,在两市A股市值排名2181/5206。本周关注点公司公告汇总:威高骨科2025年年度权益分派实施公告显示,每股现金红利0.24元(含税),股权登记日为2026年6月25日。公司公告汇总:本次权益分派合计派发现金红利95,348,669.76元(含税),占2025年度合并归属于公司股东净利润的35.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644828690","title":"威高骨科(688161)披露2025年年度权益分派实施公告,6月18日股价上涨1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644828690","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644828690?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:54","pubTimestamp":1781794458,"startTime":"0","endTime":"0","summary":"近日,公司发布《山东威高骨科材料股份有限公司2025年年度权益分派实施公告》:每股现金红利0.24元(含税),股权登记日为2026年6月25日,除权(息)日及现金红利发放日均为2026年6月26日。本次利润分配以实施权益分派时股权登记日的总股本扣减回购专用账户股份后的股份数为基数,合计派发现金红利95,348,669.76元(含税),占2025年度合并归属于公司股东净利润的35.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800043049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639602893","title":"每周股票复盘:威高骨科(688161)2025年年度股东会顺利召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2639602893","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639602893?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:38","pubTimestamp":1780173491,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,威高骨科报收于26.38元,较上周的26.27元上涨0.42%。本周关注点公司公告汇总:威高骨科2025年年度股东会于2026年5月28日召开,表决结果合法有效。山东威高骨科材料股份有限公司于2026年5月28日召开2025年年度股东会,会议由董事会召集,董事长陈敏女士主持,采用现场与网络投票相结合方式召开。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001447.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638694656","title":"威高骨科(688161)披露2025年年度股东会决议公告,5月28日股价下跌2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638694656","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638694656?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:47","pubTimestamp":1779979629,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘,威高骨科报收于26.42元,较前一交易日下跌2.44%,最新总市值为105.68亿元。该股当日开盘27.08元,最高27.08元,最低26.03元,成交额达2903.48万元,换手率为0.27%。近日,山东威高骨科材料股份有限公司发布《2025年年度股东会决议公告》。公告显示,公司于2026年5月28日召开2025年年度股东会,出席会议的股东及代理人共77人,代表有表决权股份总数332,719,101股,占公司总表决权股份的83.7480%。其中,日常关联交易议案涉及关联股东回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638544165","title":"威高骨科新注册《制造生产数据采集与分析管理系统V1.0》等2个项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2638544165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638544165?lang=zh_cn&edition=full","pubTime":"2026-05-27 02:11","pubTimestamp":1779819075,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科(688161)新注册了2个项目的软件著作权,包括《制造生产数据采集与分析管理系统V1.0》、《车间生产数据实时采集与处理系统V1.0》等。今年以来威高骨科新注册软件著作权2个。结合公司2025年年报财务数据,2025年公司在研发方面投入了1.12亿元,同比减6.34%。通过天眼查大数据分析,山东威高骨科材料股份有限公司共对外投资了22家企业,参与招投标项目576次;财产线索方面有商标信息1条,专利信息362条,著作权信息1条;此外企业还拥有行政许可129个。数据来源:天眼查APP以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700001833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159180","BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637376637","title":"每周股票复盘:威高骨科(688161)2025年净利增20.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637376637","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637376637?lang=zh_cn&edition=full","pubTime":"2026-05-24 04:44","pubTimestamp":1779569054,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,威高骨科报收于26.27元,较上周的27.1元下跌3.06%。本周,威高骨科5月19日盘中最高价报27.35元。威高骨科当前最新总市值105.08亿元,在医疗器械板块市值排名30/129,在两市A股市值排名1983/5206。2025年公司实现营业收入152,279.40万元,同比增长4.82%;归属于上市公司股东的净利润26,864.35万元,同比增长20.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636452338","title":"威高骨科(688161)披露2025年年度股东会会议资料,5月20日股价下跌1.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636452338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636452338?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:27","pubTimestamp":1779272832,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,威高骨科报收于26.63元,较前一交易日下跌1.66%,最新总市值为106.52亿元。该股当日开盘27.03元,最高27.03元,最低26.55元,成交额达3264.94万元,换手率为0.31%。近日,山东威高骨科材料股份有限公司发布2025年年度股东会会议资料。2025年公司实现营业收入152,279.40万元,同比增长4.82%;归属于上市公司股东的净利润26,864.35万元,同比增长20.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000035704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636062131","title":"每周股票复盘:威高骨科(688161)将参加2026年投资者网上集体接待日活动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636062131","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636062131?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:42","pubTimestamp":1778964131,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,威高骨科报收于27.1元,较上周的28.9元下跌6.23%。本周,威高骨科5月11日盘中最高价报29.23元。威高骨科当前最新总市值108.4亿元,在医疗器械板块市值排名28/129,在两市A股市值排名1931/5203。本周关注点公司公告汇总:威高骨科将参加2026年5月15日举行的山东辖区上市公司投资者网上集体接待日活动。公司高管将就2025年度业绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等话题与投资者进行交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635100788","title":"威高骨科(688161)披露将参加2026年山东辖区上市公司投资者网上集体接待日活动,5月13日股价下跌0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635100788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635100788?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:09","pubTimestamp":1778666980,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,威高骨科报收于28.26元,较前一交易日下跌0.18%,最新总市值为113.04亿元。山东威高骨科材料股份有限公司于近日发布《关于参加2026年山东辖区上市公司投资者网上集体接待日活动的公告》。公告显示,公司将于2026年5月15日15:00-16:30通过网络远程方式参加由山东证监局、山东上市公司协会与深圳市全景网络有限公司联合举办的“2026年山东辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300033877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634841222","title":"每周股票复盘:威高骨科(688161)签订募集资金监管协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2634841222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634841222?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:50","pubTimestamp":1778356220,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,威高骨科报收于28.9元,较上周的27.86元上涨3.73%。本周,威高骨科5月7日盘中最高价报29.44元。本周关注点公司公告汇总:威高骨科签订募集资金专户存储三方监管协议,专户用于研发中心建设。公司公告汇总山东威高骨科材料股份有限公司于2026年3月26日召开董事会,审议通过增加募集资金投资项目实施主体及开立募集资金专户的议案。协议明确各方对募集资金的监管责任,确保专款专用,并按规定履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640628","title":"每周股票复盘:威高骨科(688161)Q1净利降14.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640628","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632640628?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:45","pubTimestamp":1777668313,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,威高骨科报收于27.86元,较上周的31.45元下跌11.41%。本周,威高骨科4月27日盘中最高价报31.86元。威高骨科当前最新总市值111.44亿元,在医疗器械板块市值排名27/129,在两市A股市值排名1841/5200。业绩披露要点财务报告威高骨科2026年一季报显示,一季度公司主营收入2.96亿元,同比上升2.12%;归母净利润4422.96万元,同比下降14.6%;扣非净利润4086.71万元,同比下降16.71%;负债率18.53%,投资收益619.81万元,财务费用-20.52万元,毛利率60.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631682377","title":"威高骨科(688161)披露2026年第一季度报告,4月30日股价下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631682377","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631682377?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:50","pubTimestamp":1777542635,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,威高骨科报收于27.86元,较前一交易日下跌5.24%,最新总市值为111.44亿元。该股当日开盘29.2元,最高29.2元,最低27.6元,成交额达1.71亿元,换手率为1.52%。公司于2026年4月30日披露《山东威高骨科材料股份有限公司2026年第一季度报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000057893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631659441","title":"图解威高骨科一季报:第一季度单季净利润同比下降14.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631659441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631659441?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:27","pubTimestamp":1777458431,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2026年一季报显示,一季度公司主营收入2.96亿元,同比上升2.12%;归母净利润4422.96万元,同比下降14.6%;扣非净利润4086.71万元,同比下降16.71%;负债率18.53%,投资收益619.81万元,财务费用-20.52万元,毛利率60.48%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900058855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631966395","title":"威高骨科(688161)3月31日股东户数0.96万户,较上期减少3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631966395","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631966395?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:42","pubTimestamp":1777455762,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年3月31日公司股东户数为9603.0户,较2月28日减少377.0户,减幅为3.78%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2026年2月28日至2026年3月31日,威高骨科区间涨幅为1.28%,在此期间股东户数减少377.0户,减幅为3.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625199625","title":"东吴证券:给予威高骨科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625199625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625199625?lang=zh_cn&edition=full","pubTime":"2026-04-06 07:35","pubTimestamp":1775432114,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广近期对威高骨科进行研究并发布了研究报告《骨科平台型公司,全球化布局提速》,给予威高骨科买入评级。 盈利预测与投资评级:考虑到公司并购整合后费用可能略有增加,我们将公司2026-2027年归母净利润由3.64/4.20亿元下调至3.36/4.14亿元,预计2028年归母净利润为5.01亿元,对应当前市值的PE分别为36/29/24倍,考虑到公司海外发展顺利,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有1家机构给出评级,买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040600000116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535715","title":"股市必读:威高骨科年报 - 第四季度单季净利润同比增长2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535715","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623535715?lang=zh_cn&edition=full","pubTime":"2026-03-30 02:25","pubTimestamp":1774808712,"startTime":"0","endTime":"0","summary":"来自:威高骨科2025年归母净利润同比增长20.06%,第四季度营收增速达12.75%。股本股东变化股东户数变动近日威高骨科披露,截至2026年2月28日公司股东户数为9980.0户,较12月31日减少102.0户,减幅为1.01%。2025年度董事会工作报告山东威高骨科材料股份有限公司2025年度董事会工作报告显示,公司实现营业收入152,279.40万元,同比增长4.82%;归属于上市公司股东的净利润26,864.35万元,同比增长20.06%;经营活动现金流量净额41,541.71万元,同比增长51.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623133505","title":"威高骨科(688161)2025年年报简析:营收净利润同比双双增长,公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2623133505","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623133505?lang=zh_cn&edition=full","pubTime":"2026-03-29 06:14","pubTimestamp":1774736065,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期威高骨科发布2025年年报。本报告期威高骨科公司应收账款体量较大,当期应收账款占最新年报归母净利润比达107.53%。去年的净利率为17.98%,算上全部成本后,公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622638522","title":"威高骨科(688161)2月28日股东户数1万户,较上期减少1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622638522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622638522?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:04","pubTimestamp":1774688674,"startTime":"0","endTime":"0","summary":"证券之星消息,近日威高骨科披露,截至2026年2月28日公司股东户数为9980.0户,较12月31日减少102.0户,减幅为1.01%。在医疗器械行业个股中,威高骨科股东户数低于行业平均水平,截至2月28日,医疗器械行业平均股东户数为2.16万户。从股价来看,2025年12月31日至2026年2月28日,威高骨科区间涨幅为8.88%,在此期间股东户数减少102.0户,减幅为1.01%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622874122","title":"图解威高骨科年报:第四季度单季净利润同比增长2.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622874122","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622874122?lang=zh_cn&edition=full","pubTime":"2026-03-28 01:38","pubTimestamp":1774633095,"startTime":"0","endTime":"0","summary":"证券之星消息,威高骨科2025年年报显示,当年度公司主营收入15.23亿元,同比上升4.82%;归母净利润2.69亿元,同比上升20.06%;扣非净利润2.55亿元,同比上升20.77%;其中2025年第四季度,公司单季度主营收入4.17亿元,同比上升12.75%;单季度归母净利润6123.78万元,同比上升2.99%;单季度扣非净利润6023.02万元,同比上升16.81%;负债率17.82%,投资收益3092.44万元,财务费用-955.91万元,毛利率64.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800003737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782639072036,"stockEarnings":[{"period":"1week","weight":-0.0659},{"period":"1month","weight":-0.2467},{"period":"3month","weight":-0.3355},{"period":"6month","weight":-0.2794},{"period":"1year","weight":-0.2235},{"period":"ytd","weight":-0.2693}],"compareEarnings":[{"period":"1week","weight":-0.0155},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.029},{"period":"6month","weight":0.016},{"period":"1year","weight":0.1678},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东威高骨科材料股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"9603人(较上一季度减少3.78%)","perCapita":"41653股","listingDate":"2021-06-30","address":"山东省威海市环翠区旅游度假区香江街26号","registeredCapital":"40000万元","survey":" 山东威高骨科材料股份有限公司的主营业务是骨科医疗器械的研发,生产和销售。公司的主要产品是骨科植入物及耗材类产品、骨科智能设备与耗材类产品、功能修复与组织再生类产品。公司是国内产品线最全、规模领先的头部企业之一,市场份额增长远超行业平均增速。公司在国内市场上建立了较高的品牌知名度,在国产高端医疗器械领域具有较高的市场占有率。","listedPrice":36.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"威高骨科,688161,威高骨科股票,威高骨科股票老虎,威高骨科股票老虎国际,威高骨科行情,威高骨科股票行情,威高骨科股价,威高骨科股市,威高骨科股票价格,威高骨科股票交易,威高骨科股票购买,威高骨科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"威高骨科(688161)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供威高骨科(688161)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}